[P1] Poster Session (1) / Corporate Exhibits

Flash TalksVaccine Science

[P1-17] Construction and evaluation of novel AAV vector vaccines aimed at effective immune induction

*Ken Sugo¹, Hiroshi Ueki^2,3,4, Yuji Tsunekawa¹, Emiko Urano⁵, Yukage Kobari¹, Yasunari Matsuzaka¹, Koji Kobiyama⁶, Guillermo Posadas-Herrera¹, Hiromi Hayashita-Kinoh¹, Mikako Wada¹, Yukihiko Hirai¹, Yasushi Soda¹, Yasuhiro Yasutomi^7,8,9, Ken J. Ishii^{6,10,11,12,13}, Seiya Yamayoshi^2,3,4, Yoshihiro Kawaoka^2,3,4, Takashi Okada¹ (1. Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo (Japan), 2. Division of Virology, The Institute of Medical Science, The University of Tokyo (Japan), 3. Center for Global Viral Diseases, National Institute of Global Health and Medicine (Japan), 4. The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA) (Japan), 5. Laboratory of Immunoregulation and Vaccine Research, Tsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN) (Japan), 6. Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo (Japan), 7. Tsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN) (Japan), 8. School of Integrative and Global Majors, University of Tsukuba (Japan), 9. Department of Immunoregulation, Mie University Graduate School of Medicine (Japan), 10. Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo (Japan), 11. Graduate School of Medicine and Faculty of Medicine, The University of Tokyo (Japan), 12. International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo (Japan), 13. Laboratory of Vaccine Science, Immunology Frontier Research Center, The University of Osaka (Japan))

Keywords:

Adeno-associated virus,AAV vector vaccine,SARS-CoV-2

Password required to view

Log in

or